WPRE-mediated enhancement of gene expression is promoter and cell line specific

Gene

Volumn 372, Issue 1-2, 2006, Pages 153-161

  Klein, Reinhard ^a   Ruttkowski, Bärbel ^b   Knapp, Elzbieta ^b   Salmons, Brian ^a   Günzburg, Walter H ^b   Hohenadl, Christine ^a,b  

^a Austrianova Biomanufacturing Company   (Austria)

^b UNIVERSITY OF VETERINARY MEDICINE   (Austria)

Author keywords

MMTV promoter; Promoter conversion; Retroviral vector; Tissue specific expression; WAP promoter

Indexed keywords

ACID PROTEIN; CIS ACTING ELEMENT; ENHANCED GREEN FLUORESCENT PROTEIN; RETROVIRUS VECTOR; RNA; UNCLASSIFIED DRUG; VIRUS VECTOR; WOODCHUCK HEPATITIS POST TRANSCRIPTONAL REGULATORY ELEMENT;

ANIMAL CELL; ARTICLE; CELL SPECIFICITY; CONTROLLED STUDY; EMBRYO; GENE EXPRESSION; HUMAN; HUMAN CELL; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; MURINE LEUKEMIA VIRUS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; RETROVIRUS; TRANSGENE; VIRUS TITRATION;

ANIMALS; CELL LINE; CELLS, CULTURED; DOGS; GENE EXPRESSION; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HEPATITIS B VIRUS, WOODCHUCK; HUMANS; LEUKEMIA VIRUS, MURINE; MICE; ORGAN SPECIFICITY; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; VIRUS ASSEMBLY;

ANIMALIA; LEUKEMIA VIRUS; MARMOTA MONAX; MOUSE MAMMARY TUMOR VIRUS; MURINAE; MURINE LEUKEMIA VIRUS;

EID: 33646051851     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gene.2005.12.018     Document Type: Article

References (35)

1. Cailleau R., Olive M., and Cruciger Q.V. Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization. In Vitro 14 (1978) 911-915
2. Crandell R.A., Fabricant C.G., and Nelson-Rees W.A. Development, characterization, and viral susceptibility of a feline (Felis catus) renal cell line (CRFK). In Vitro 9 (1973) 176-185
3. Dangerfield J.A., Hohenadl C., Egerbacher M., Kodajova P., Salmons B., and Günzburg W.H. HIV-1 Rev can specifically interact with MMTV RNA and upregulate gene expression. Gene 358 (2005) 17-30
4. Donello J.E., Loeb J.E., and Hope T.J. Woodchuck hepatitis virus contains a tripartite posttranscriptional regulatory element. J. Virol. 72 (1998) 5085-5092
5. Graham F.L., Smiley J., Russell W.C., and Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36 (1977) 59-74
6. Hlavaty J., Portsmouth D., Stracke A., Salmons B., Günzburg W.H., and Renner M. Effects of sequences of prokaryotic origin on titer and transgene expression in retroviral vectors. Virology 330 (2004) 351-360
7. Hlavaty J., Stracke A., Klein D., Salmons B., Günzburg W.H., and Renner M. Multiple modifications allow high-titer production of retroviral vectors carrying heterologous regulatory elements. J. Virol. 78 (2004) 1384-1392
8. Hlavaty J., et al. Effect of posttranscriptional regulatory elements on transgene expression and virus production in the context of retrovirus vectors. Virology 341 (2005) 1-11
9. Jainchill J.L., Aaronson S.A., and Todaro G.J. Murine sarcoma and leukemia viruses: assay using clonal lines of contact-inhibited mouse cells. J. Virol. 4 (1969) 549-553
10. Johansen J., Tornoe J., Moller A., and Johansen T.E. Increased in vitro and in vivo transgene expression levels mediated through cis-acting elements. J. Gene Med. 5 (2003) 1080-1089
11. Ketteler R., Glaser S., Sandra O., Martens U.M., and Klingmüller U. Enhanced transgene expression in primitive hematopoietic progenitor cells and embryonic stem cells efficiently transduced by optimized retroviral hybrid vectors. Gene Ther. 9 (2002) 477-487
12. Keydar I., et al. Establishment and characterization of a cell line of human breast carcinoma origin. Eur. J. Cancer 15 (1979) 659-670
13. Klein D., Bugl B., Günzburg W.H., and Salmons B. Accurate estimation of transduction efficiency necessitates a multiplex real-time PCR. Gene Ther. 7 (2000) 458-463
14. Klein D., et al. Influence of preassay and sequence variations on viral load determination by a multiplex real-time reverse transcriptase-polymerase chain reaction for feline immunodeficiency virus. J. Acquir. Immune Defic. Syndr. 26 (2001) 8-20
15. Kraunus J., et al. Self-inactivating retroviral vectors with improved RNA processing. Gene Ther. 11 (2004) 1568-1578
16. Lengler J., Holzmüller H., Salmons B., Günzburg W.H., and Renner M. FMDV-2A sequence and protein arrangement contribute to functionality of CYP2B1-reporter fusion protein. Anal. Biochem. 343 (2005) 116-124
17. Lipnik K., et al. A 470 bp WAP-promoter fragment confers lactation independent, progesterone regulated mammary-specific gene expression in transgenic mice. Transgenic. Res. 14 (2005) 145-158
18. Loeb J.E., Cordier W.S., Harris M.E., Weitzman M.D., and Hope T.J. Enhanced expression of transgenes from adeno-associated virus vectors with the woodchuck hepatitis virus posttranscriptional regulatory element: implications for gene therapy. Hum. Gene Ther. 10 (1999) 2295-2305
19. Moreau-Gaudry F., et al. High-level erythroid-specific gene expression in primary human and murine hematopoietic cells with self-inactivating lentiviral vectors. Blood 98 (2001) 2664-2672
20. Mrochen S., Klein D., Nikol S., Smith J.R., Salmons B., and Günzburg W.H. Inducible expression of p21WAF-1/CIP-1/SDI-1 from a promoter conversion retroviral vector. J. Mol. Med. 75 (1997) 820-828
21. Nelson-Rees W.A., Owens R.B., Arnstein P., and Kniazeff A.J. Source, alterations, characteristics and use of a new dog cell line (Cf2Th). In Vitro 12 (1976) 665-669
22. Öztürk-Winder F., Renner M., Klein D., Müller M., Salmons B., and Günzburg W.H. The murine whey acidic protein promoter directs expression to human mammary tumors after retroviral transduction. Cancer Gene Ther. 9 (2002) 421-431
23. Pambalk K., Hohenadl C., Salmons B., Günzburg W.H., and Renner M. Specific packaging of spliced retroviral vector transcripts lacking the Psi-region. Biochem. Biophys. Res. Commun. 293 (2002) 239-246
24. Paterna J.C., Moccetti T., Mura A., Feldon J., and Bueler H. Influence of promoter and WHV post-transcriptional regulatory element on AAV-mediated transgene expression in the rat brain. Gene Ther. 7 (2000) 1304-1311
25. Popa I., Harris M.E., Donello J.E., and Hope T.J. CRM1-dependent function of a cis-acting RNA export element. Mol. Cell Biol 22 (2002) 2057-2067
26. Ramezani A., Hawley T.S., and Hawley R.G. Lentiviral vectors for enhanced gene expression in human hematopoietic cells. Mol. Ther. 2 (2000) 458-469
27. Riggs J.L., McAllister R.M., and Lennette E.H. Immunofluorescent studies of RD-114 virus replication in cell culture. J. Gen. Virol. 25 (1974) 21-29
28. Saller R.M., Öztürk F., Salmons B., and Günzburg W.H. Construction and characterization of a hybrid mouse mammary tumor virus/murine leukemia virus-based retroviral vector. J. Virol. 72 (1998) 1699-1703
29. Salmons B., and Günzburg W.H. Targeting of retroviral vectors for gene therapy. Hum. Gene Ther. 4 (1993) 129-141
30. Schambach A., Wodrich H., Hildinger M., Bohne J., Krausslich H.G., and Baum C. Context dependence of different modules for posttranscriptional enhancement of gene expression from retroviral vectors. Mol. Ther. 2 (2000) 435-445
31. Schwenter F., Deglon N., and Aebischer P. Optimization of human erythropoietin secretion from MLV-infected human primary fibroblasts used for encapsulated cell therapy. J. Gene Med. 5 (2003) 246-257
32. Soule H.D., Vazguez J., Long A., Albert S., and Brennan M. A human cell line from a pleural effusion derived from a breast carcinoma. J. Natl. Cancer Inst. 51 (1973) 1409-1416
33. Weber E., Anderson W.F., and Kasahara N. Recent advances in retrovirus vector-mediated gene therapy: teaching an old vector new tricks. Curr. Opin. Mol. Ther. 3 (2001) 439-453
34. Werner M., Kraunus J., Baum C., and Brocker T. B-cell-specific transgene expression using a self-inactivating retroviral vector with human CD19 promoter and viral post-transcriptional regulatory element. Gene Ther. 11 (2004) 992-1000
35. Zufferey R., Donello J.E., Trono D., and Hope T.J. Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J. Virol. 73 (1999) 2886-2892